Unknown PHASE2 INTERVENTIONAL 2-arm NCT01417390

Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Randomized Phase Ⅱ Trial of Induction Chemotherapy Using Gemcitabine and Cisplatin in Concurrence With Intensity-modulated Radiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma

Sponsor: First People's Hospital of Foshan

Conditions Nasopharyngeal Carcinoma

Interventions Cisplatin Drug: Gemcitabine and cisplatin

Updated 5 times since 2017 Last updated: Mar 6, 2014 Started: Nov 30, 2011 Primary completion: Dec 31, 2014 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Nasopharyngeal Carcinoma, this trial is ongoing. The trial is conducted by First People's Hospital of Foshan and has accumulated 5 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

First People's Hospital of Foshan

Data source: First People's Hospital of Foshan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Foshan, China